Liquidia Corporation Common Stock (LQDA) is a publicly traded Healthcare sector company. As of September 30, 2026, LQDA trades at $53.43 with a market cap of $6.59B and a P/E ratio of 44.81. LQDA moved -25.32% today. Year to date, LQDA is +104.96%; over the trailing twelve months it is +210.04%. Its 52-week range spans $11.26 to $93.61. Analyst consensus is buy with an average price target of $106.71. Rallies surfaces LQDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LQDA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $53.43 |
| Market Cap | $6.59B |
| P/E Ratio | 44.81 |
| EPS | $1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $93.61 |
| 52-Week Low | $11.26 |
| Volume | 2.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $450.91M |
| Net Income | $138.61M |
| Gross Margin | 0.00% |
7 analysts cover LQDA: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $106.71.